Monoclonal Antibodies Market Size, Share & Trends Report

Monoclonal Antibodies Market Size, Share & Trends Analysis Report By Source Type (Chimeric, Murine, Humanized, Human), By Production Type (In Vivo, In Vitro), By Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-1-68038-280-8
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2020
  • Industry: Healthcare

Market Segmentation 

  • Source type Outlook (Revenue, USD Billion, 2018 - 2030)
    • Murine
    • Chimeric
    • Humanized
    • Human
  • Production Type Outlook (Revenue, USD Billion, 2018 - 2030)
    • In Vivo
    • In Vitro
  • Application Outlook (Revenue, USD Billion, 2018 - 2030)
    • Oncology
    • Autoimmune Diseases
    • Infectious Diseases
    • Neurological Diseases
    • Others
  • Global Monoclonal Antibodies: End-use Outlook (Revenue, USD Billion, 2018 - 2030)
    • Hospitals
    • Specialty Centers
    • Others
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
    • North America
      • North America Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
        • Murine
        • Chimeric
        • Humanized
        • Human
      • North America Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
        • In Vivo
        • In Vitro
      • North America Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
        • Oncology
        • Autoimmune Diseases
        • Infectious Diseases
        • Neurological Diseases
        • Others
      • North America Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
        • Hospitals
        • Specialty Centers
        • Others
      • U.S.
        • U.S. Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • U.S. Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • U.S. Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • U.S. Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
      • Canada
        • Canada Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • Canada Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • Canada Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • Canada Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
    • Europe
      • Europe Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
        • Murine
        • Chimeric
        • Humanized
        • Human
      • Europe Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
        • In Vivo
        • In Vitro
      • Europe Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
        • Oncology
        • Autoimmune Diseases
        • Infectious Diseases
        • Neurological Diseases
        • Others
      • Europe Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
        • Hospitals
        • Specialty Centers
        • Others
      • UK
        • UK Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • UK Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • UK Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • UK Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
      • Germany
        • Germany Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • Germany Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • Germany Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • Germany Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
      • France
        • France Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • France Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • France Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • France Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
      • Italy
        • Italy Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • Italy Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • Italy Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • Italy Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
      • Spain
        • Spain Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • Spain Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • Spain Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • Spain Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
    • Asia Pacific
      • Asia Pacific Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
        • Murine
        • Chimeric
        • Humanized
        • Human
      • Asia Pacific Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
        • In Vivo
        • In Vitro
      • Asia Pacific Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
        • Oncology
        • Autoimmune Diseases
        • Infectious Diseases
        • Neurological Diseases
        • Others
      • Asia Pacific Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
        • Hospitals
        • Specialty Centers
        • Others
      • Japan
        • Japan Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • Japan Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • Japan Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • Japan Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
      • China
        • China Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • China Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • China Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • China Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
      • India
        • India Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • India Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • India Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • India Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
      • Australia
        • Australia Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • Australia Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • Australia Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • Australia Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
      • South Korea
        • South Korea Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • South Korea Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • South Korea Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • South Korea Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
    • Latin America
      • Latin America Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
        • Murine
        • Chimeric
        • Humanized
        • Human
      • Latin America Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
        • In Vivo
        • In Vitro
      • Latin America Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
        • Oncology
        • Autoimmune Diseases
        • Infectious Diseases
        • Neurological Diseases
        • Others
      • Latin America Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
        • Hospitals
        • Specialty Centers
        • Others
      • Brazil
        • Brazil Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • Brazil Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • Brazil Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • Brazil Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
      • Mexico
        • Mexico Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • Mexico Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • Mexico Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • Mexico Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
    • MEA
      • MEA Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
        • Murine
        • Chimeric
        • Humanized
        • Human
      • MEA Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
        • In Vivo
        • In Vitro
      • MEA Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
        • Oncology
        • Autoimmune Diseases
        • Infectious Diseases
        • Neurological Diseases
        • Others
      • MEA Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
        • Hospitals
        • Specialty Centers
        • Others
      • South Africa
        • South Africa Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • South Africa Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • South Africa Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • South Africa Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
      • Saudi Arabia
        • Saudi Arabia Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • Saudi Arabia Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • Saudi Arabia Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • Saudi Arabia Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others
      • UAE
        • UAE Monoclonal Antibodies Market, By Source type, 2018 - 2030 (USD Billion)
          • Murine
          • Chimeric
          • Humanized
          • Human
        • UAE Monoclonal Antibodies Market, By Production Type, 2018 - 2030 (USD Billion)
          • In Vivo
          • In Vitro
        • UAE Monoclonal Antibodies Market, By Application, 2018 - 2030 (USD Billion)
          • Oncology
          • Autoimmune Diseases
          • Infectious Diseases
          • Neurological Diseases
          • Others
        • UAE Monoclonal Antibodies Market, By End-use, 2018 - 2030 (USD Billion)
          • Hospitals
          • Specialty Centers
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.